The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence

Laura E. Klein, B. Scott Freeze, Amos B. Smith, Susan Band Horwitz

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Discodermolide is a microtubule stabilizing agent that suppresses dynamic instability and blocks cells in mitosis. Selection of A549 nonsmall cell lung carcinoma cells with increasing concentrations of discodermolide yielded a clone that proliferated in 8 nM. When these cells were exposed to any concentration greater than 8 nM, replication ceased and the cells developed a flattened, enlarged, granular morphology. Accelerated senescence was demonstrated by a functional β-galactosidase activity at pH 6. When parental A549 cells were treated with IC50-concentrations of doxorubicin, Taxol or discodermolide, the latter two drugs quickly produced aberrant mitosis. However, discodermolide, but not Taxol, also produced a large increase in senescence-associated β-galactosidase activity and altered levels of known senescence markers. Although some of these differences between Taxol and discodermolide were dose dependent, only discodermolide produced a doxorubicin-like induction of a senescence phenotype, including a senescence-associated β-galactosidase activity, up-regulation of PAI-1 and p66Shc, and a strong, sustained, Erk1/2 activation. This research provides insights into the mechanism of action of discodermolide and provides the first demonstration of a microtubule stabilizing agent that inhibits tumor cell growth with a powerful induction of accelerated senescence.

Original languageEnglish (US)
Pages (from-to)501-507
Number of pages7
JournalCell Cycle
Volume4
Issue number3
StatePublished - Mar 2005

Fingerprint

Cell Aging
Excipients
Helper-Inducer T-Lymphocytes
Microtubules
Galactosidases
Paclitaxel
Mitosis
Doxorubicin
Cells
Plasminogen Activator Inhibitor 1
Cell growth
discodermolide
Inhibitory Concentration 50
Tumors
Up-Regulation
Demonstrations
Clone Cells
Chemical activation
Carcinoma
Phenotype

Keywords

  • Accelerated senescence
  • Apoptosis
  • Discodermolide
  • Mitotic catastrophe
  • Taxol®

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Cite this

The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. / Klein, Laura E.; Freeze, B. Scott; Smith, Amos B.; Band Horwitz, Susan.

In: Cell Cycle, Vol. 4, No. 3, 03.2005, p. 501-507.

Research output: Contribution to journalArticle

Klein, Laura E. ; Freeze, B. Scott ; Smith, Amos B. ; Band Horwitz, Susan. / The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. In: Cell Cycle. 2005 ; Vol. 4, No. 3. pp. 501-507.
@article{843aae4220c54915a4cef4e66e4ef672,
title = "The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence",
abstract = "Discodermolide is a microtubule stabilizing agent that suppresses dynamic instability and blocks cells in mitosis. Selection of A549 nonsmall cell lung carcinoma cells with increasing concentrations of discodermolide yielded a clone that proliferated in 8 nM. When these cells were exposed to any concentration greater than 8 nM, replication ceased and the cells developed a flattened, enlarged, granular morphology. Accelerated senescence was demonstrated by a functional β-galactosidase activity at pH 6. When parental A549 cells were treated with IC50-concentrations of doxorubicin, Taxol or discodermolide, the latter two drugs quickly produced aberrant mitosis. However, discodermolide, but not Taxol, also produced a large increase in senescence-associated β-galactosidase activity and altered levels of known senescence markers. Although some of these differences between Taxol and discodermolide were dose dependent, only discodermolide produced a doxorubicin-like induction of a senescence phenotype, including a senescence-associated β-galactosidase activity, up-regulation of PAI-1 and p66Shc, and a strong, sustained, Erk1/2 activation. This research provides insights into the mechanism of action of discodermolide and provides the first demonstration of a microtubule stabilizing agent that inhibits tumor cell growth with a powerful induction of accelerated senescence.",
keywords = "Accelerated senescence, Apoptosis, Discodermolide, Mitotic catastrophe, Taxol{\circledR}",
author = "Klein, {Laura E.} and Freeze, {B. Scott} and Smith, {Amos B.} and {Band Horwitz}, Susan",
year = "2005",
month = "3",
language = "English (US)",
volume = "4",
pages = "501--507",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "3",

}

TY - JOUR

T1 - The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence

AU - Klein, Laura E.

AU - Freeze, B. Scott

AU - Smith, Amos B.

AU - Band Horwitz, Susan

PY - 2005/3

Y1 - 2005/3

N2 - Discodermolide is a microtubule stabilizing agent that suppresses dynamic instability and blocks cells in mitosis. Selection of A549 nonsmall cell lung carcinoma cells with increasing concentrations of discodermolide yielded a clone that proliferated in 8 nM. When these cells were exposed to any concentration greater than 8 nM, replication ceased and the cells developed a flattened, enlarged, granular morphology. Accelerated senescence was demonstrated by a functional β-galactosidase activity at pH 6. When parental A549 cells were treated with IC50-concentrations of doxorubicin, Taxol or discodermolide, the latter two drugs quickly produced aberrant mitosis. However, discodermolide, but not Taxol, also produced a large increase in senescence-associated β-galactosidase activity and altered levels of known senescence markers. Although some of these differences between Taxol and discodermolide were dose dependent, only discodermolide produced a doxorubicin-like induction of a senescence phenotype, including a senescence-associated β-galactosidase activity, up-regulation of PAI-1 and p66Shc, and a strong, sustained, Erk1/2 activation. This research provides insights into the mechanism of action of discodermolide and provides the first demonstration of a microtubule stabilizing agent that inhibits tumor cell growth with a powerful induction of accelerated senescence.

AB - Discodermolide is a microtubule stabilizing agent that suppresses dynamic instability and blocks cells in mitosis. Selection of A549 nonsmall cell lung carcinoma cells with increasing concentrations of discodermolide yielded a clone that proliferated in 8 nM. When these cells were exposed to any concentration greater than 8 nM, replication ceased and the cells developed a flattened, enlarged, granular morphology. Accelerated senescence was demonstrated by a functional β-galactosidase activity at pH 6. When parental A549 cells were treated with IC50-concentrations of doxorubicin, Taxol or discodermolide, the latter two drugs quickly produced aberrant mitosis. However, discodermolide, but not Taxol, also produced a large increase in senescence-associated β-galactosidase activity and altered levels of known senescence markers. Although some of these differences between Taxol and discodermolide were dose dependent, only discodermolide produced a doxorubicin-like induction of a senescence phenotype, including a senescence-associated β-galactosidase activity, up-regulation of PAI-1 and p66Shc, and a strong, sustained, Erk1/2 activation. This research provides insights into the mechanism of action of discodermolide and provides the first demonstration of a microtubule stabilizing agent that inhibits tumor cell growth with a powerful induction of accelerated senescence.

KW - Accelerated senescence

KW - Apoptosis

KW - Discodermolide

KW - Mitotic catastrophe

KW - Taxol®

UR - http://www.scopus.com/inward/record.url?scp=21744449331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744449331&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 501

EP - 507

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 3

ER -